Identification of , a Retrotransposon-Derived Imprinted Gene, as a Novel Driver of Hepatocarcinogenesis

English version České info

We previously utilized a Sleeping Beauty (SB) transposon mutagenesis screen to discover novel drivers of HCC. This approach identified recurrent mutations within the Dlk1-Dio3 imprinted domain, indicating that alteration of one or more elements within the domain provides a selective advantage to cells during the process of hepatocarcinogenesis. For the current study, we performed transcriptome and small RNA sequencing to profile gene expression in SB–induced HCCs in an attempt to clarify the genetic element(s) contributing to tumorigenesis. We identified strong induction of Retrotransposon-like 1 (Rtl1) expression as the only consistent alteration detected in all SB–induced tumors with Dlk1-Dio3 integrations, suggesting that Rtl1 activation serves as a driver of HCC. While previous studies have identified correlations between disrupted expression of multiple Dlk1-Dio3 domain members and HCC, we show here that direct modulation of a single domain member, Rtl1, can promote hepatocarcinogenesis in vivo. Overexpression of Rtl1 in the livers of adult mice using a hydrodynamic gene delivery technique resulted in highly penetrant (86%) tumor formation. Additionally, we detected overexpression of RTL1 in 30% of analyzed human HCC samples, indicating the potential relevance of this locus as a therapeutic target for patients. The Rtl1 locus is evolutionarily derived from the domestication of a retrotransposon. In addition to identifying Rtl1 as a novel driver of HCC, our study represents one of the first direct in vivo demonstrations of a role for such a co-opted genetic element in promoting carcinogenesis.

Vyšlo v časopise: Identification of , a Retrotransposon-Derived Imprinted Gene, as a Novel Driver of Hepatocarcinogenesis. PLoS Genet 9(4): e32767. doi:10.1371/journal.pgen.1003441
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1003441

Souhrn

Zdroje

1. FerlayJ, ShinHR, BrayF, FormanD, MathersC, et al. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893–2917.

2. AltekruseSF, McGlynnKA, ReichmanME (2009) Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol 27: 1485–1491.

3. LlovetJM, RicciS, MazzaferroV, HilgardP, GaneE, et al. (2008) Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359: 378–390.

4. HowellVM (2012) Sleeping beauty–a mouse model for all cancers? Cancer Lett 317: 1–8.

5. DupuyAJ, RogersLM, KimJ, NannapaneniK, StarrTK, et al. (2009) A modified sleeping beauty transposon system that can be used to model a wide variety of human cancers in mice. Cancer Res 69: 8150–8156.

6. da RochaST, EdwardsCA, ItoM, OgataT, Ferguson-SmithAC (2008) Genomic imprinting at the mammalian Dlk1-Dio3 domain. Trends Genet 24: 306–316.

7. GeorgiadesP, WatkinsM, SuraniMA, Ferguson-SmithAC (2000) Parental origin-specific developmental defects in mice with uniparental disomy for chromosome 12. Development 127: 4719–4728.

8. OgataT, KagamiM, Ferguson-SmithAC (2008) Molecular mechanisms regulating phenotypic outcome in paternal and maternal uniparental disomy for chromosome 14. Epigenetics 3: 181–187.

9. DonsanteA, MillerDG, LiY, VoglerC, BruntEM, et al. (2007) AAV vector integration sites in mouse hepatocellular carcinoma. Science 317: 477.

10. WangPR, XuM, ToffaninS, LiY, LlovetJM, et al. (2012) Induction of hepatocellular carcinoma by in vivo gene targeting. Proc Natl Acad Sci U S A 109: 11264–11269.

11. BraconiC, KogureT, ValeriN, HuangN, NuovoG, et al. (2011) microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer. Oncogene 30: 4750–4756.

12. HuangJ, ZhangX, ZhangM, ZhuJD, ZhangYL, et al. (2007) Up-regulation of DLK1 as an imprinted gene could contribute to human hepatocellular carcinoma. Carcinogenesis 28: 1094–1103.

13. LukJM, BurchardJ, ZhangC, LiuAM, WongKF, et al. (2011) DLK1-DIO3 genomic imprinted microRNA cluster at 14q32.2 defines a stemlike subtype of hepatocellular carcinoma associated with poor survival. J Biol Chem 286: 30706–30713.

14. YuF, HaoX, ZhaoH, GeC, YaoM, et al. (2010) Delta-like 1 contributes to cell growth by increasing the interferon-inducible protein 16 expression in hepatocellular carcinoma. Liver Int 30: 703–714.

15. RanzaniM, CesanaD, BartholomaeCC, SanvitoF, PalaM, et al. (2013) Lentiviral vector-based insertional mutagenesis identifies genes associated with liver cancer. Nat Methods 10: 155–161.

16. YoungsonNA, KocialkowskiS, PeelN, Ferguson-SmithAC (2005) A small family of sushi-class retrotransposon-derived genes in mammals and their relation to genomic imprinting. J Mol Evol 61: 481–490.

17. EdwardsCA, MungallAJ, MatthewsL, RyderE, GrayDJ, et al. (2008) The evolution of the DLK1-DIO3 imprinted domain in mammals. PLoS Biol 6: e135 doi:10.1371/journal.pbio.0060135.

18. SteshinaEY, CarrMS, GlickEA, YevtodiyenkoA, AppelbeOK, et al. (2006) Loss of imprinting at the Dlk1-Gtl2 locus caused by insertional mutagenesis in the Gtl2 5′ region. BMC Genet 7: 44.

19. SeitzH, YoungsonN, LinSP, DalbertS, PaulsenM, et al. (2003) Imprinted microRNA genes transcribed antisense to a reciprocally imprinted retrotransposon-like gene. Nat Genet 34: 261–262.

20. BrettBT, Berquam-VriezeKE, NannapaneniK, HuangJ, ScheetzTE, et al. (2011) Novel molecular and computational methods improve the accuracy of insertion site analysis in Sleeping Beauty-induced tumors. PLoS ONE 6: e24668 doi:10.1371/journal.pone.0024668.

21. LiX, EwisH, HiceRH, MalaniN, ParkerN, et al. (2013) A resurrected mammalian hAT transposable element and a closely related insect element are highly active in human cell culture. Proc Natl Acad Sci U S A 110: E478–487.

22. WoodardLE, LiX, MalaniN, KajaA, HiceRH, et al. (2012) Comparative analysis of the recently discovered hAT transposon TcBuster in human cells. PLoS ONE 7: e42666 doi:10.1371/journal.pone.0042666.

23. O'DonnellKA, KengVW, YorkB, ReinekeEL, SeoD, et al. (2012) A Sleeping Beauty mutagenesis screen reveals a tumor suppressor role for Ncoa2/Src-2 in liver cancer. Proc Natl Acad Sci U S A 109: E1377–1386.

24. KengVW, VillanuevaA, ChiangDY, DupuyAJ, RyanBJ, et al. (2009) A conditional transposon-based insertional mutagenesis screen for genes associated with mouse hepatocellular carcinoma. Nat Biotechnol 27: 264–274.

25. HarriL, PhilippeC, FedericoB, ArneM, ValerieD, et al. (2012) Identification of Dlk1-Dio3 imprinted gene cluster non-coding RNAs as novel candidate biomarkers for liver tumor promotion. Toxicol Sci 131: 375–86.

26. SeitzHK, StickelF (2006) Risk factors and mechanisms of hepatocarcinogenesis with special emphasis on alcohol and oxidative stress. Biol Chem 387: 349–360.

27. ZhangDY, FriedmanSL (2012) Fibrosis-dependent mechanisms of hepatocarcinogenesis. Hepatology 56: 769–775.

28. BellJB, Podetz-PedersenKM, AronovichEL, BelurLR, McIvorRS, et al. (2007) Preferential delivery of the Sleeping Beauty transposon system to livers of mice by hydrodynamic injection. Nat Protoc 2: 3153–3165.

29. WangensteenKJ, WilberA, KengVW, HeZ, MatiseI, et al. (2008) A facile method for somatic, lifelong manipulation of multiple genes in the mouse liver. Hepatology 47: 1714–1724.

30. GrompeM, OverturfK, al-DhalimyM, FinegoldM (1998) Therapeutic trials in the murine model of hereditary tyrosinaemia type I: a progress report. J Inherit Metab Dis 21: 518–531.

31. KengVW, TschidaBR, BellJB, LargaespadaDA (2011) Modeling hepatitis B virus X-induced hepatocellular carcinoma in mice with the Sleeping Beauty transposon system. Hepatology 53: 781–790.

32. ShuldinerAR, NirulaA, RothJ (1990) RNA template-specific polymerase chain reaction (RS-PCR): a novel strategy to reduce dramatically false positives. Gene 91: 139–142.

33. FeinbergAP, TyckoB (2004) The history of cancer epigenetics. Nat Rev Cancer 4: 143–153.

34. HolmTM, Jackson-GrusbyL, BrambrinkT, YamadaY, RideoutWM3rd, et al. (2005) Global loss of imprinting leads to widespread tumorigenesis in adult mice. Cancer Cell 8: 275–285.

35. HoshidaY, NijmanSM, KobayashiM, ChanJA, BrunetJP, et al. (2009) Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma. Cancer Res 69: 7385–7392.

36. MoothaVK, LindgrenCM, ErikssonKF, SubramanianA, SihagS, et al. (2003) PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34: 267–273.

37. SubramanianA, TamayoP, MoothaVK, MukherjeeS, EbertBL, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102: 15545–15550.

38. SekitaY, WagatsumaH, NakamuraK, OnoR, KagamiM, et al. (2008) Role of retrotransposon-derived imprinted gene, Rtl1, in the feto-maternal interface of mouse placenta. Nat Genet 40: 243–248.

39. MarciniszynJJr, HartsuckJA, TangJ (1976) Mode of inhibition of acid proteases by pepstatin. J Biol Chem 251: 7088–7094.

40. WoodJM, MaibaumJ, RahuelJ, GrutterMG, CohenNC, et al. (2003) Structure-based design of aliskiren, a novel orally effective renin inhibitor. Biochem Biophys Res Commun 308: 698–705.

41. RobinsonBS, RiccardiKA, GongYF, GuoQ, StockDA, et al. (2000) BMS-232632, a highly potent human immunodeficiency virus protease inhibitor that can be used in combination with other available antiretroviral agents. Antimicrob Agents Chemother 44: 2093–2099.

42. MortazaviA, WilliamsBA, McCueK, SchaefferL, WoldB (2008) Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods 5: 621–628.

43. de HoonMJ, ImotoS, NolanJ, MiyanoS (2004) Open source clustering software. Bioinformatics 20: 1453–1454.

44. SaldanhaAJ (2004) Java Treeview–extensible visualization of microarray data. Bioinformatics 20: 3246–3248.

45. DickinsRA, HemannMT, ZilfouJT, SimpsonDR, IbarraI, et al. (2005) Probing tumor phenotypes using stable and regulated synthetic microRNA precursors. Nat Genet 37: 1289–1295.